Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma.
Davies AJ, Rohatiner AZ, Howell S, Britton KE, Owens SE, Micallef IN, Deakin DP, Carrington BM, Lawrance JA, Vinnicombe S, Mather SJ, Clayton J, Foley R, Jan H, Kroll S, Harris M, Amess J, Norton AJ, Lister TA, Radford JA.
Davies AJ, et al. Among authors: rohatiner az.
J Clin Oncol. 2004 Apr 15;22(8):1469-79. doi: 10.1200/JCO.2004.06.055.
J Clin Oncol. 2004.
PMID: 15084620
Clinical Trial.